Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 ...

Shares of Nevro Corp. (NYSE:NVRO – Get Free Report ... Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the ...

According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $5.36. Nevro Corp., a medical device company, engages in the provision ...

GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device ... impact the market sentiment toward GMED stock. Globus Medical has a market capitalization ...

NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals.

REDWOOD CITY, CA – Nevro Corp , a medical device company with annual ... conversion of all outstanding shares of Nevro’s common stock into a right to receive $5.85 per share in cash.

Nevro Corp. common stock ceased trading on the New York Stock Exchange prior to the open of the market on April 3, 2025. Further information about the transaction can be found in the Form 8-Ks ...

GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive ... we anticipate that the latest acquisition should positively ...